| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RENOVARO INC. | Director | Option to purchase shares of common stock | 42.9K | Jun 25, 2024 | Direct | ||
| Mirum Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 15.6K | Jun 2, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RENB | RENOVARO INC. | Jun 25, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| RENB | RENOVARO INC. | Dec 27, 2023 | 1 | $0 | 4 | Feb 28, 2024 | Director |
| RENB | Enochian Biosciences Inc | Dec 27, 2022 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| MIRM | Mirum Pharmaceuticals, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
| RENB | Enochian Biosciences Inc | Dec 27, 2021 | 1 | $0 | 4 | Jan 3, 2022 | Director |
| MIRM | Mirum Pharmaceuticals, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director |
| MIRM | Mirum Pharmaceuticals, Inc. | Jun 4, 2021 | 0 | $0 | 3 | Jun 8, 2021 | Director |
| RENB | Enochian Biosciences Inc | Apr 6, 2020 | 2 | $0 | 4 | Dec 21, 2021 | Director |